2020-12-28,Is Aclaris Therapeutics (NASDAQ:ACRS) Weighed On By Its Debt Load?
2020-12-23,Implied Volatility Surging for Aclaris Therapeutics (ACRS) Stock Options
2020-12-15,Is ACRS A Good Stock To Buy Now?
2020-12-15,Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
2020-11-16,Aclaris Therapeutics to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
2020-11-14,How Much Does Aclaris Therapeutics' (NASDAQ:ACRS) CEO Make?
2020-11-06,Aclaris (ACRS) Upgraded to Buy: Here's What You Should Know
2020-11-04,"Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates"
2020-11-04,Aclaris Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
2020-10-29,Aclaris Therapeutics (ACRS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
2020-10-21,Aclaris (ACRS) Begins Phase II Study on Eczema Candidate
2020-10-20,"Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-1777, an Investigational Topical Soft JAK 1/3 Inhibitor, for the Treatment of Moderate to Severe Atopic Dermatitis"
2020-10-14,"Hedge Funds Are Buying Aclaris Therapeutics, Inc. (ACRS)"
2020-10-01,All You Need to Know About Aclaris (ACRS) Rating Upgrade to Buy
2020-09-30,"Could The Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Ownership Structure Tell Us Something Useful?"
2020-09-01,Aclaris Therapeutics to Present at Upcoming Investor Conferences
2020-08-13,Aclaris (ACRS) Upgraded to Buy: Here's What You Should Know
2020-08-07,"Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-07,Aclaris Therapeutics Reports Second Quarter 2020 Financial Results and Provides R&D and Business Highlights
2020-08-06,Will Aclaris Therapeutics (ACRS) Report Negative Q2 Earnings? What You Should Know
2020-07-08,Aclaris (ACRS) Surges: Stock Moves 5.4% Higher
2020-07-07,"Aclaris Therapeutics Submits Investigational New Drug Application for ATI-1777, a Topical Soft JAK1/3 Inhibitor, for the Treatment of Moderate to Severe Atopic Dermatitis"
2020-06-26,"Is Aclaris Therapeutics, Inc. (ACRS) A Good Stock To Buy?"
2020-06-18,Aclaris Gets FDA Nod to Start Investigator-led Coronavirus Study
2020-06-17,P/E Ratio Insights for Aclaris Therapeutics
2020-06-17,Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release Syndrome in Hospitalized Patients with COVID-19
2020-06-03,"Aclaris Therapeutics Announces Publication of an Abstract of the Phase 1 Clinical Trial Results for ATI-450, an Investigational Compound, at the EULAR 2020 E-Congress"
2020-05-26,Aclaris Therapeutics to Present at the Jefferies Virtual Healthcare Conference
2020-05-12,Will Aclaris Therapeutics Continue to Surge Higher?
2020-05-08,All You Need to Know About Aclaris (ACRS) Rating Upgrade to Buy
2020-05-07,Aclaris Therapeutics Reports First Quarter 2020 Financial Results and Provides R&D and Business Highlights
2020-05-06,Aclaris Therapeutics (ACRS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
2020-04-09,"Does The Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Share Price Fall With The Market?"
2020-04-06,Aclaris (ACRS) Upgraded to Buy: Here's Why
2020-04-01,Wayne biopharma firm borrows $11M to fund new business strategy
2020-03-31,Aclaris Therapeutics Secures $11 Million Term Loan Facility
2020-03-17,Edited Transcript of ACRS earnings conference call or presentation 25-Feb-20 10:00pm GMT
2020-02-25,Aclaris Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides R&D and Business Highlights
2020-02-24,"Is Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) CEO Paid At A Competitive Rate?"
2020-02-19,"Aclaris Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020"
2020-02-10,Aclaris Therapeutics to Present at the SVB Leerink 9th Annual Global Healthcare Conference
2020-01-13,Aclaris' MK2 Inhibitor Shows Encouraging Data in Phase I
2020-01-10,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx"
2020-01-10,Some Aclaris Therapeutics (NASDAQ:ACRS) Shareholders Have Taken A Painful 94% Share Price Drop
2020-01-09,"Aclaris Therapeutics Announces Positive Results From Phase 1 Single and Multiple Ascending Dose Trial of ATI-450, an Investigational Oral MK2 Inhibitor"
2020-01-08,Aclaris Therapeutics Announces Appointment of Vincent Milano to Board of Directors
2019-12-24,Aclaris (ACRS) Upgraded to Buy: Here's Why
2019-12-12,"Did Hedge Funds Drop The Ball On Aclaris Therapeutics, Inc. (ACRS) ?"
2019-11-27,"Shareholder Alert: Robbins LLP Announces Another Complaint Filed Against Aclaris Therapeutics, Inc. (ACRS)"
2019-11-21,"Shareholder Alert: Robbins LLP Announces Another Complaint Filed Against Aclaris Therapeutics, Inc. (ACRS)"
2019-11-18,Rigel Gets Positive CHMP Review for Thrombocytopenia Drug
2019-11-17,Edited Transcript of ACRS earnings conference call or presentation 7-Nov-19 10:00pm GMT
2019-11-12,Aclaris Therapeutics to Present at Upcoming Investor Conferences
2019-11-07,Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights and an Update on R&D Programs
2019-10-31,"Aclaris Therapeutics to Announce Third Quarter 2019 Financial Results on November 7, 2019"
2019-10-29,Aclaris Therapeutics (ACRS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
2019-10-25,"The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug"
2019-10-24,Aclaris Therapeutics A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Second Successful Pivotal Phase 3 Clinical Trial for the Treatment of Common Warts (THWART-1)
2019-10-17,"Company News for Oct 17, 2019"
2019-10-14,"Aclaris Divests Rhofade to EPI Health for $55M, Shares Up"
2019-10-11,Wayne biopharma sells rosacea therapy in deal that could bring in $55M
2019-10-10,Aclaris Therapeutics Announces Divestiture of RHOFADE®
2019-10-09,"The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug"
2019-10-08,"Aclaris Therapeutics Files Patent Infringement Lawsuit Against Taro Pharmaceuticals, Inc. for Filing an ANDA for a Generic Version of RHOFADE® (oxymetazoline hydrochloride) cream, 1%"
2019-10-08,Edited Transcript of ACRS earnings conference call or presentation 8-Aug-19 9:00pm GMT
2019-10-07,"Does Market Volatility Impact Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) Share Price?"
2019-10-06,"Bragar Eagel & Squire is Investigating Certain Officers and Directors of PriceSmart, Pyxus, Aclaris Therapeutics, and Zimmer Biomet Holdings and Encourages Investors to Contact the Firm"
2019-10-03,Top Ranked Momentum Stocks to Buy for October 3rd
2019-09-30,"FINAL DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm"
2019-09-30,"FINAL SEPT. 30 DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Reminds Aclaris Therapeutics, Inc. Investors of Important Deadline in Securities Class Action  ACRS"
2019-09-28,"DEADLINE MONDAY: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm"
2019-09-28,"DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Aclaris Therapeutics, Inc. (NYSE: ACRS) and Encourages Aclaris Investors to Contact the Firm"
2019-09-27,"FINAL DEADLINE MONDAY: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm"
2019-09-27,"Sarepta Therapeutics, Inc. (SRPT), Aclaris Therapeutics, Inc. (ACRS) & Canada Goose Holdings Inc. (GOOS) - Class Action Update - Bronstein, Gewirtz & Grossman, LLC"
2019-09-27,Top Ranked Momentum Stocks to Buy for September 27th
2019-09-27,"DEADLINE ALERT for ACRS, GTT, JE, and NKTR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders"
2019-09-27,"Sarepta Therapeutics, Inc. (SRPT), Aclaris Therapeutics, Inc. (ACRS) & Canada Goose Holdings Inc. (GOOS) - Class Action - Bronstein, Gewirtz & Grossman, LLC"
2019-09-26,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aclaris Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ACRS
2019-09-26,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aclaris Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ACRS
2019-09-26,"Pawar Law Group Reminds Investors of September 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc.  ACRS"
2019-09-26,"Aclaris Therapeutics, Inc. (ACRS) Shares March Higher, Can It Continue?"
2019-09-25,"DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Aclaris Therapeutics, Inc. (NASDAQ: ACRS) and Encourages Aclaris Investors to Contact the Firm"
2019-09-25,"ACLARIS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aclaris Therapeutics, Inc. To Contact The Firm"
2019-09-25,"5-Day Deadline Alert: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm"
2019-09-25,"Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aclaris Therapeutics, Inc."
2019-09-25,"Sarepta Therapeutics, Inc. (SRPT), Aclaris Therapeutics, Inc. (ACRS) & Canada Goose Holdings Inc. (GOOS) - Class Action Update - Bronstein, Gewirtz & Grossman, LLC"
2019-09-25,Aclaris (ACRS) Moves to Buy: Rationale Behind the Upgrade
2019-09-24,"6-Day Deadline Alert: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm"
2019-09-24,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aclaris Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline  ACRS
2019-09-24,"Zhang Investor Law Reminds Investors of Sept. 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc.  ACRS"
2019-09-24,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aclaris Therapeutics, Inc. To Contact The Firm"
2019-09-23,"Sarepta Therapeutics, Inc. (SRPT), Aclaris Therapeutics, Inc. (ACRS) & Canada Goose Holdings Inc. (GOOS) - Class Action Alert - Bronstein, Gewirtz & Grossman, LLC"
2019-09-23,"7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"
2019-09-20,"GTT Communications, Inc. (GTT), Sarepta Therapeutics, Inc. (SRPT) & Aclaris Therapeutics, Inc. (ACRS) - Class Action Alert - Bronstein, Gewirtz & Grossman, LLC"
2019-09-20,"GLOBALLY RECOGNIZED ROSEN LAW FIRM Reminds Aclaris Therapeutics, Inc. Investors of Important September 30th Deadline in Securities Class Action  ACRS"
2019-09-20,"Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aclaris Therapeutics, Inc."
2019-09-20,"GTT Communications, Inc. (GTT), Sarepta Therapeutics, Inc. (SRPT) & Aclaris Therapeutics, Inc. (ACRS) - Class Actions - Bronstein, Gewirtz & Grossman, LLC"
2019-09-19,"IMPORTANT SEPTEMBER DEADLINE: The Schall Law Firm Announces it is Investigating Claims Against Aclaris Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm"
2019-09-19,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aclaris Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ACRS
2019-09-19,"DEADLINE: Pawar Law Group Reminds Investors of September 30 Deadline in Securities Class Action Lawsuit Against Aclaris Therapeutics, Inc. - ACRS"
